Previous editions
Muy Global | Ed. 22 | Jul 2024
• Tirzepatide: Eli Lilly's alternative for sleep apnea.
• Anesthetics shortage in Colombia: SCARE alerts INVIMA.
• Torsemide for dogs: FDA grants conditional approval.
• Shipping crisis: Delays and high demand.
Muy Global | Ed. 21 | May 2024
• Novo Nordisk in action: Increasing supply of Wegovy.
• Artificial Intelligence accelerates small molecule development.
• RSV vaccine development in progress: Modern at the vanguard.
• Innovative platform for container tracking: Hapag-Lloyd revolutionizes logistics.
Muy Global | Ed. 20 | Apr 2024
• Alliance between Invima and University of Antioquia: Looking to promote public production of medicines.
• Impact on maritime transportation: Disruptions in the Panama and Suez canals.
• Colombia and Japan join forces: Alliance for the study of a vaccine against Mpox.
• FDA approves Idorsia's Tryvio: Indicated for persistent hypertension.
Subscribe
Keep informed of the most important news of the pharmaceutical industry